New Hope for Depression
In this piece for TIME, Mandy Oaklander provides a comprehensive review of the current status of and potential future directions for the depression treatment industry. The...
The Psychedelic Renaissance is Here. Will it Last This Time?
From Massive: Increasing evidence suggests that psychedelics may revolutionize mental health care. In order for this "psychedelic renaissance" to last, scientists and citizens will need...
Sunday History Channel: Seventy-five Years of Psychedelic Psychiatry
Mo Costandi provides a brief history in The Guardian of research activities using psychedelic substances such as LSD for psychiatric and psychotherapeutic purposes. Costandi...
Dissolving the Ego: Transcendence and Ecstasy
From Aeon: Experiencing ecstasy and transcendence has long been pathologized and marginalized by Western culture and the psychiatric model of "mental illness." However, ecstatic experiences, including...
The Promise of LSD Microdoses and Other Psychedelics
In this interview for Scientific American, psychiatrist John Halpern discusses some of the potentially therapeutic effects of peyote, ayahuasca, psilocybin, MDMA and other psychedelics.
"Once when...
“Scientists Push to Renew Psychedelic Drug Research for Psychiatry”
-CBC Radio interviews UK neuropsychopharmacologist David Nutt, Mark Haden of MAPS, and historian Erika Dyck about the past and present politics and science of psychedelic research.
The Important Drugs Debate Question That Nobody’s Asking
In this piece for Vice, Max Daly explores the impact of societal attitudes toward drug use and drug users on the drug policy debate over prohibition...
“Trust” In Therapeutic Relationship Key to Moderating Psychedelic Risks
-Psychiatry Advisor reports on psychiatrist James Rucker's campaign for more research into the therapeutic potentials of psychedelic drugs, and on critics who point to the risks.
Psychedelic Use Associated with Reductions in Suicidal Tendencies
People who have taken a psychedelic drug at least once have less suicidal thinking than the general population.
British Government Plans to Illegalize All Unapproved Psychoactive Substances
A Kings College London psychiatrist worries what broad new British restrictions on psychoactive substances could mean for psychedelic research.
What Are “Hard” and “Soft” Drugs?
From Neuroskeptic: A new paper examines the often arbitrary distinction between "hard" and "soft" drugs, recommending that scientists avoid using these classifications in research publications.
Article âÂ
Researchers Describe “Mind-blowing” Findings With Psychedelics
-Michael Pollan visits the resurgence of interest in the psychotherapeutic properties of psychedelic drugs in an essay in The New Yorker.
Sunday Meditation: Are Non-ordinary States “Freeing” the Brain to Truly See?
On his blog Metaphysical Speculations, Bernardo Kastrup challenges conventional psychiatric assumptions that the brain produces and controls consciousness. Kastrup cites two recent studies published...
Can Psychedelics Help End Addictions with One Dose?
Q13 Fox News discusses recent research giving psychedelics to people struggling with alcohol or cigarettes. David Nutt, an Imperial College London neuro-psychopharmacologist "thinks psilocybin...
“Healing with MDMA-assisted Psychotherapy” and Other Psychedelic Stories
The Multi-Disciplinary Association for Psychedelic Studies' Winter 2014 Bulletin is freely available. Among other articles, the issue includes a personal story of a patient,...
Tripping for Knowledge: The Psychedelic Epistemologist
In this interview for 3:AM Magazine, Chris Letheby argues that even though psychedelics may induce delusions or imaginary phenomena, their use can also lead to accurate...
âClub Drug Ketamine Gains Traction As A Treatment For Depressionâ
NPR reports on how ketamine is being used off-label to treat depression.
“Can psychedelic trips cure PTSD and other maladies?”
The Washington Post explores some of the history of research into the therapeutic potentials of even just one session with a psychedelic drug, and...
Top Psychiatrist Fired In “Political” Row Over PTSD-Marijuana Study
A psychiatrist at the University of Arizona was fired after state Republican Senators criticized her work to university officials, according to the New York...
âFDA Agrees to New Trials for Ecstasy as Relief for PTSD Patientsâ
Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. âIf they can keep...
âWarning Over Ketamine Use for Depressionâ
The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to âjump the gun in prescribing patients the drug ketamine to treat depression.â
âFlimsy Evidenceâ for Esketamine as Depression Treatment
A new article documents the âflimsy evidenceâ behind the recent FDA approval of the party drug esketamine for the treatment of depression.
‘Ego-Dissolving’ Psychedelic Drugs Could Improve Mental Health
From Medical Xpress: Researchers have proposed that psychedelic drugs such as LSD and magic mushrooms may help some people with anxiety, depression, and addiction by dissolving...
“The Manual of Psychedelic Support”
-Zevic Mishor writes about the development and release of a free guide to supporting people through extreme states induced by the use of psychedelic drugs.
Despite âFlurry of Interest,â Ketamine Remains Unproven For Depression
In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine âmight be the most important breakthrough in antidepressant treatment in decades.â A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.
